CNBC’s Jim Cramer explains why he is keeping an eye on shares of Intuitive Surgical. Novak Djokovic makes two-word admission ...

Shares of Intuitive Surgical (NASDAQ: ISRG) were pulling back today as a strong fourth-quarter earnings report didn't seem to ...

Intuitive Surgical (NASDAQ: ISRG) Q4 2024 Earnings Call Jan 23, 2025, 4:30 p.m. ET Good day, and thank you for standing by.

We assign Intuitive Surgical a High Morningstar Uncertainty Rating.

Intuitive Surgical stock crumbled Friday after the robotic surgery giant issued lackluster gross margin guidance for 2025.

Intuitive Surgical reported fourth-quarter revenue of $2.41 billion, beating the consensus estimate of $2.25 billion. The ...

BofA raised the firm’s price target on Intuitive Surgical (ISRG) to $700 from $600 and keeps a Buy rating on the shares. Intuitive’s Q4 ...

Intuitive Surgical (ISRG – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Travis ...

Intuitive's sales and profits exceeded expectations, but a warning about Trump's import tax proposal may have worried ...

With the full-scale launch of its latest surgical robot set for the middle of this year, Intuitive said that, to date, the ...

Intuitive Surgical, Inc. (ISRG) is currently at $585.26, down $23.40 or 3.84% --Would be lowest close since Jan. 16, 2025, when it closed at $584.08 --On pace for largest percent decrease since Oct.

About 13% of American men will develop prostate cancer at some point, putting their erectile function at risk.